Literature DB >> 21480132

Comparison of the surgical outcomes of thoracoscopic lobectomy, segmentectomy, and wedge resection for clinical stage I non-small cell lung cancer.

H Nakamura1, Y Taniguchi, K Miwa, Y Adachi, S Fujioka, T Haruki, Y Takagi, Y Yurugi.   

Abstract

BACKGROUND: Video-assisted thoracoscopic surgery (VATS) for clinical stage I non-small cell lung cancer (NSCLC) has been widely used as a less invasive surgical procedure, but the resection method is still controversial. We retrospectively compared the surgical outcomes of lobectomy, segmentectomy and wedge resection. PATIENTS AND METHODS: A total of 411 patients with clinical stage I NSCLC who underwent VATS (218 males and 193 females, aged 69.3 years; 345 adenocarcinomas, 57 squamous cell carcinomas, and 9 others) were investigated. The surgical procedure was lobectomy in 289, segmentectomy in 38, and wedge resection in 84. Surgical outcomes were compared among these 3 groups.
RESULTS: Demographic characteristics showed that the rate of elderly and male patients was higher in the wedge resection group. The 5-year survival rates for the lobectomy, segmentectomy, and wedge resection groups were 82.1, 87.2, and 55.4%, respectively. In the wedge resection group, the 5-year survival rate was 83.3% in patients undergoing intentional low-risk operations for small tumors with ground glass opacity, and 41.1% in those undergoing conservative high-risk operations because of comorbidities. Using Cox's proportional multivariate analysis and sex differences, histology, and tumor size as co-influential factors, the surgical procedure was found to be a significantly poor prognostic factor, and the hazard ratio of wedge resection relative to lobectomy was 4.30.
CONCLUSION: The outcomes of VATS lobectomy and segmentectomy procedures for clinical stage I NSCLC were equivalent, while the outcome for VATS wedge resection was inferior. VATS wedge resection for clinical stage I NSCLC should be carefully indicated and requires adequate patient selection. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21480132     DOI: 10.1055/s-0030-1250377

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  40 in total

1.  Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Benedetta Bedetti; Luca Bertolaccini; Raffaele Rocco; Joachim Schmidt; Piergiorgio Solli; Marco Scarci
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 2.  Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I non-small-cell lung cancer?

Authors:  Maya K De Zoysa; Dima Hamed; Tom Routledge; Marco Scarci
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-27

3.  Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.

Authors:  Jun-Ichi Nitadori; Christos Colovos; Kyuichi Kadota; Camelia S Sima; Inderpal S Sarkaria; Nabil P Rizk; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

4.  Developing the guidelines: the techniques of uniportal VATS for sublobar resection and middle lobectomy.

Authors:  Arthur Vieira; Ricardo Oliveira; Ivan Salgado de Azevedo; Paula Ugalde Figueroa
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 5.  VATS segmentectomy: past, present, and future.

Authors:  Seshiru Nakazawa; Kimihiro Shimizu; Akira Mogi; Hiroyuki Kuwano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-12-18

6.  Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Akikazu Kawase; Nobumasa Takahashi; Takeshi Kawaguchi; Tetsukan Woo; Yuichi Saito; Satoshi Shiono; Noriyuki Matsutani
Journal:  Surg Today       Date:  2018-06-19       Impact factor: 2.549

7.  Open, thoracoscopic and robotic segmentectomy for lung cancer.

Authors:  Chi-Fu Jeffrey Yang; Thomas A D'Amico
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 8.  Anatomical thoracoscopic segmentectomy for lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-03

Review 9.  Lung cancer surgery: an up to date.

Authors:  Nikolaos Baltayiannis; Michail Chandrinos; Dimitrios Anagnostopoulos; Paul Zarogoulidis; Kosmas Tsakiridis; Andreas Mpakas; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

10.  Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3.

Authors:  Zhize Chen; Yang Wu; Qingtao Meng; Zhongyuan Xia
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-09-28       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.